UltraSight

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://ultrasight.com/

Last Round

Series B

Extension

Sep 23, 2026

Total Funding Raised

$15M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

UltraSight is a health tech company that provides an AI-powered software platform to guide medical professionals in acquiring cardiac ultrasound images.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

cardiac ultrasoundPOCUSpoint-of-care ultrasoundAI ultrasoundechocardiographymedical imaging AIultrasound guidanceAI medical devicecardiac diagnosticscomputer visionclinical decision supportAI-guided imagingmedical softwarehealthcare SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UltraSight Comparables

Compare UltraSight with similar companies based on industry and business-model similarity.

UltraSight comparables — related companies by embedding similarity
Company	Similarity	Market Cap
GE HealthCare Technologies Inc.	81%
Exo	78%
ThinkSono	78%

View all Comparables

UltraSight Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B Extension	Sep 23, 2026
Series B	May 11, 2021
Series A	Mar 19, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Itay Kezurer

Co-Founder CTO

Founding Team

Davidi Vortman

Chief Executive Officer

Executive Team

Ramya Singh

Chief Commercial Officer

Executive Team

UltraSight Investors

Notable investors and investment history

UltraSight investors
Investor	Rounds
Weizmann Institute of Science	Series B
ARC Innovation Center	Seed
Connecticut Innovations	Series B Extension
MedTech Innovator	Seed
Deep Insight	Series B Extension
Star51 Capital	Series B Extension
eHealth Ventures	Series B Extension

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 23, 2026
$24M round led by ALIVE Israel HealthTech Fund.
Mar 3, 2026
Presented at the 2026 Technology and Heart Failure Therapeutics (THT) Conference.

View all signals

UltraSight Filings

Explore SEC and related filing metadata, where available.

UltraSight filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range32

Year Founded2018

Last FundingSep 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?